Business Context and Reporting Period
This Form 8-K is a current report filed by Biokeys Pharmaceuticals, Inc. (noted as Savara Inc in metadata) on February 4, 2003. The filing addresses a change in the registrant's certifying accountant and the appointment of a new independent auditor.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity for the current period. However, it references historical audit reports indicating the company has suffered recurring losses from operations, raising substantial doubt about its ability to continue as a going concern.
Material Changes
- Dismissal of Accountant: On February 4, 2003, the registrant dismissed KPMG LLP as its independent accountants. The Board of Directors approved this dismissal on January 27, 2003.
- Appointment of New Accountant: The registrant engaged J.H. Cohn LLP as its new independent accountants, effective February 5, 2003.
- Audit History: KPMG LLP's audit reports for fiscal years ended December 31, 2001, and 2000 contained no adverse opinions but were modified due to uncertainty regarding the company's ability to continue as a going concern.
Management Commentary, Risks, and Contingencies
Internal Control Weaknesses: KPMG LLP identified material weaknesses in the registrant's internal controls during audits for 2000 and 2001. These weaknesses included:
- Failure to perform standard accounting functions on a monthly or quarterly basis.
- Lack of timely reconciliations between bank accounts and the general ledger.
- Failure to segregate cash management tasks among officers and employees.
- Failure to maintain a full set of final, executed documents for equity transactions.
- Failure to routinely update the list of outstanding warrants with details such as exercise price and expiration date.
Disagreements: The registrant reported no disagreements with KPMG LLP regarding accounting principles, financial statement disclosures, or auditing scope. Similarly, no consultations regarding accounting principles or disagreements occurred with the new accountant, J.H. Cohn LLP, prior to their engagement.
Investor Verification Checklist
- Verify the status of the "going concern" uncertainty noted in prior audit reports.
- Confirm the implementation of remedial policies to address the five specific internal control weaknesses identified by KPMG LLP.
- Review the letter from KPMG LLP (Exhibit 16) to confirm their agreement with the registrant's statements regarding the dismissal.
- Monitor the transition of audit responsibilities to J.H. Cohn LLP effective February 5, 2003.